首页 | 本学科首页   官方微博 | 高级检索  
     


Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma
Authors:Boris Böll  Peter Borchmann  Max S. Topp  Mathias Hänel  Katrin S. Reiners  Andreas Engert  Ralph Naumann
Affiliation:1. German Hodgkin Study Group and Internal Medicine I, University Hospital Cologne, Cologne;2. Internal Medicine, University Hospital Wuerzburg, Wuerzburg;3. Internal Medicine III, Hospital Chemnitz, Chemnitz;4. Internal Medicine, Stiftungsklinikum Mittelrhein Koblenz, Koblenz, Germany.
E‐mail: Peter.Borchmann@uni‐koeln.de
Abstract:
Keywords:Hodgkin lymphoma  IMIDs  thalidomide  lenalidomide  immunotherapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号